Level of evidence for therapeutic drug monitoring for etoposide after oral administration.

Abstract : Abstract Oral etoposide displays high intervariability and intravariability. Convincing relationships were observed between hematological toxicities and exposure of which total etoposide area under the curve seems the more relevant in routine practice. Linear pharmacokinetics, limited sampling strategies and reduction in variability during concentration-controlled studies argue in favor of therapeutic drug monitoring. However, such reduction in variability should be confirmed after oral administration. For these reasons, such practice can be considered as 'potentially useful'. Further studies using Bayesian approach are nevertheless needed to definitely state regarding the level of evidence therapeutic drug monitoring of oral etoposide.
Type de document :
Article dans une revue
Fundamental & Clinical Pharmacology, 2010, epub ahead of print. 〈10.1111/j.1472-8206.2010.00856.x〉
Liste complète des métadonnées

http://www.hal.inserm.fr/inserm-00508039
Contributeur : Philippe Saas <>
Soumis le : lundi 2 août 2010 - 14:47:52
Dernière modification le : lundi 9 juillet 2018 - 13:12:02

Lien texte intégral

Identifiants

Collections

Citation

Pauline Gerritsen-Van Schieveen, Bernard Royer. Level of evidence for therapeutic drug monitoring for etoposide after oral administration.. Fundamental & Clinical Pharmacology, 2010, epub ahead of print. 〈10.1111/j.1472-8206.2010.00856.x〉. 〈inserm-00508039〉

Partager

Métriques

Consultations de la notice

77